ProCE Banner Activity

Single-Agent PARP Inhibitors in Prostate Cancer

Slideset Download
Download these slides from a live Webinar for the latest evidence on PARP inhibitor monotherapy and factors that impact response to PARP inhibition in metastatic castration-resistant prostate cancer.

Released: June 15, 2021

Expiration: June 14, 2022

No longer available for credit.

Share

Faculty

Wassim Abida

Wassim Abida, MD, PhD

Director of Translational Research, Prostate Cancer
Associate Member
Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer, Inc.

Faculty Disclosure

Primary Author

Wassim Abida, MD, PhD

Director of Translational Research, Prostate Cancer
Associate Member
Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York